California is joining with a New Jersey company to make a generic opioid overdose reversal drug
California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan
Stay updated with breaking news from Mark Ghaly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan
The 3% cap, approved Wednesday by the Health Care Affordability Board, would be phased in over five years, starting with 3.5% in 2025.
The 3% cap, approved Wednesday by the Health Care Affordability Board, would be phased in over five years, starting with 3.5% in 2025.
California launched two teletherapy apps as part of the governor’s $500 million foray into health technology with private companies. But the rollout has been so slow that one company has yet to make its app available on Android, and social workers worry youths who need clinical care won’t get referrals.
Hundreds of patients of the Stanislaus Surgical Hospital in Modesto could soon lose access to care.